Why is FMC stock collapsing today?

FMC Corporation's stock fell 32% in pre-market trading after slashing its Q3 revenue forecast to $65M–$125M (down from $840M–$900M) and adjusting EBITDA to -$565M to -$510M. The company announced restructuring actions to improve competitiveness. Analysts have recently cut price targets, with Mizuho lowering it to $12. The broader market declined slightly, amplifying selling pressure.

Original reporting
Published Oct 15, 2026, 11:44 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 11:50 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$FMC
Bearish
high confidence
Mentioned
$FMC
Relevance
9/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$FMCBearishHigh
01

Why it matters

The abrupt guidance revision eclipses prior analyst downgrades, making the news the primary catalyst for the stock's collapse.

02

Market read

FMC's sharp guidance cut and pre‑market plunge represent a high‑impact, time‑sensitive trading event.

03

What to watch

Potential upside from upcoming 2027‑2028 strategic initiatives not yet quantified.

Relevance 9/10Novelty 9/10Timing: pre‑market today

Background

FMC had posted Q2 revenue of $867.1M, a 17% YoY decline, and a GAAP loss, setting a backdrop of deteriorating fundamentals.

Company-level read

Ticker impact

$FMCBearishHigh confidence
Context

FMC issued a pre‑earnings update cutting Q3 revenue to $65‑$125M and Adjusted EBITDA to -$565M‑-$510M, triggering a 32% pre‑market plunge.

Expected impact

likely continued downside as investors price in the severe guidance cut and debt concerns

Evidence & confidence

The new guidance represents a material downgrade from prior expectations and the stock already fell 32% pre‑open; no mitigating catalyst is mentioned.

Market effects

Agricultural chemicals sector faces heightened risk perception after FMC's guidance cut.

U.S. equities showed modest weakness, with the S&P 500 edging lower.

Limited to U.S. markets; no broader macro impact noted.

Counterpoint

If the debt reduction plan succeeds, FMC could be undervalued after the sell‑off.

Key entities

  • Pierre Brondeau

    CEO of FMC who announced the commercial restructuring actions.

Related articles

$FMCHigh

KeyBanc downgrades FMC stock rating on turnaround concerns

KeyBanc downgraded FMC Corp. (NYSE:FMC) to Sector Weight, citing risks to its turnaround efforts. The stock, at $5.21, has fallen 61.5% in a year. KeyBanc set a fair value of $5.50, while InvestingPro's analysis suggests a Fair Value of $6.36. FMC plans to raise $1 billion, including $400 million in equity, and anticipates a return to growth in 2027. Jefferies initiated coverage with a Hold rating and a $6.00 price target.

$FMCMed

Fresenius Medical cuts top end of 2026 profit outlook

Fresenius Medical Care adjusted its 2026 operating income outlook, now expecting a flat to mid-single-digit percentage decline, down from a previous range of decline to increase. Q3 operating income fell 5% to €545 million, while revenue grew 1% to €4.94 billion. US same-market treatments declined 1.1%. The company faces regulatory and inflation challenges under new CEO Shervin J. Korangy.

$FMCHighAI 8/10

Why FMC Corporation Rallied Today

FMC Corporation (NYSE:FMC) shares surged 30.4% after Q3 earnings, despite an 80% revenue drop to $106M and a loss of $4.41 per share. The decline was partly due to one-time price cuts and accounting adjustments. Management guided Q4 revenue to $1.11B and positive EBITDA of $220M, with expectations of $650M EBITDA in 2024 and $760M in 2028.

$FMCHighAI 9/10

FMC Q3 Earnings Call Highlights

FMC reported Q3 revenue of $1.06B, including $639M from commercial actions, and adjusted EBITDA of -$559M. Q4 outlook was lowered, with revenue expected at $1.04B-$1.14B and adjusted EBITDA at $210M-$230M. FMC cited market challenges and pricing headwinds. The company expects full-year free cash flow to be -$350M to -$150M, including restructuring spending. FMC also announced preliminary 2027 and 2028 adjusted EBITDA targets of $650M-$730M and $760M-$840M, respectively.

$FMCHighAI 8/10

FMC (FMC) Q3 2026 Earnings Call Transcript

FMC reported Q3 2026 earnings, including a $672M EBITDA impact from commercial actions. Revenue was $106M, with underlying sales at $745M, below guidance. Adjusted EBITDA was negative $559M. The company is changing its North America business model and adjusting prices to reduce channel inventory. Q4 revenue is expected to be $1.04B-$1.14B, with adjusted EBITDA between $210M-$230M.